Investor FAQs

Where is Atea Pharmaceuticals’ corporate headquarters?

225 Franklin Street
Suite 2100
Boston, MA 02110

When did Atea begin operations?

The Company began operations in 2014.

Where is the Company incorporated?

The Company is incorporated in Delaware.

How is Atea Pharmaceuticals’ stock traded?

The Company’s common stock is listed on the NASDAQ Global Market under the symbol “AVIR”.

When did Atea go public?

Atea’s completed its initial public offering (IPO) on October 30, 2020.

When is Atea’s fiscal year end?

December 31.

Does Atea have a direct stock purchase plan?

Atea does not currently have a direct stock purchase plan.

How do I contact Atea’s transfer agent?

The Company’s Transfer Agent may be reached as follows:

American Stock Transfer & Trust Company, LLC, Shareholder Services
6201 15th Avenue, Brooklyn, NY 11219
Toll-free: (888) 921-8140
Worldwide: (718) 921-8124

Email Correspondence: Email help@astfinancial.com and add a reference to Atea Pharmaceuticals.

Whom do I contact with questions about my stock (transfer stock, change the address on my shareholder account, or replace a lost stock certificate)?

For questions about your stock please contact our transfer agent American Stock Transfer & Trust Company, LLC.

Who is Atea’s independent auditor?

The independent auditor for the Company is KPMG, LLP located in Boston, MA.

Who is Atea's legal counsel?

The legal counsel for the Company is Latham & Watkins, LLP located in Boston, MA.

Who makes up the Atea Pharmaceuticals Executive Management team and Board of Directors?

For a list of the Management team and Board of Directors, please visit the “About Atea” tab of our website www.ateapharma.com.

Where can I view Atea’s corporate news releases?

Atea’s press release archive can be viewed under the “News & Events/News Releases” section of the “Investors” page located at www.ateapharma.com.

Where can I view documents that Atea has filed with the securities and exchange commission (SEC)?

Atea’s financial reports are available under the “Financials/SEC Filings” section of the “Investors” page located at www.ateapharma.com.

How can I sign up to receive Atea’s press releases and other company news?

Alerts can be set up from the “Email Alerts” section of the “Investors” page located at www.ateapharma.com.

Where can I find out more about Atea?

To find out more about Atea visit our webpage at www.ateapharma.com.

Whom should I contact if I have further questions?

Jonae Barnes, SVP, Investor Relations and Corporate Communications
617-818-2985
Barnes.jonae@ateapharma.com

Will O’Connor, Stern Investor Relations
212-362-1200
investors@ateapharma.com